MicroRNA-152 targets ADAM17 to suppress NSCLC progression

被引:64
|
作者
Su, Yunshu [1 ]
Wang, Yuchang [1 ]
Zhou, Hongmin [1 ]
Lei, Lei [1 ]
Xu, Lijun [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiothorac Surg, Wuhan 430030, Hubei, Peoples R China
来源
FEBS LETTERS | 2014年 / 588卷 / 10期
关键词
Non-small cell lung cancer; miR-152; ADAM metallopeptidase domain 17; Proliferation; Migration; Invasion; MESSENGER-RNA EXPRESSION; CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; GROWTH; PROMOTES; MOTILITY; INVASION; MIR-152; FAMILY;
D O I
10.1016/j.febslet.2014.04.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) are a class of small non-coding RNAs that have been suggested to play an essential role in tumorigenesis. In this study, we show that miR-152 is significantly downregulated in non-small cell lung cancer (NSCLC) tissues and cell lines. Restoration of miR-152 significantly reduces proliferation, colony formation, migration and invasion of NSCLC cells. In addition, ADAM metallopeptidase domain 17 (ADAM17) is identified as a target of miR-152 in NSCLC cells, and miR-152-induced suppression of cell proliferation, colony formation, migration and invasion is partially mediated by silencing of ADAM17 expression. Furthermore, ADAM17 inversely correlates with miR-152 in NSCLC tissues. Collectively, our findings indicate that miR-152 acts as tumor suppressor in NSCLC partially via targeting ADAM17. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1983 / 1988
页数:6
相关论文
共 49 条
  • [21] A microRNA-152 that targets the phosphatase and tensin homolog to inhibit low oxygen induced-apoptosis in human brain microvascular endothelial cells
    Cao, Y. H.
    Li, D. G.
    Xu, B.
    Wang, M. Q.
    Zhen, N.
    Man, L. X.
    Zhang, Y.
    Chi, M.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02)
  • [22] Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency
    Dosch, Joseph
    Ziemke, Elizabeth
    Wan, Shanshan
    Luker, Kathryn
    Welling, Theodore
    Hardiman, Karin
    Fearon, Eric
    Thomas, Suneetha
    Flynn, Matthew
    Rios-Doria, Jonathan
    Hollingsworth, Robert
    Herbst, Ronald
    Hurt, Elaine
    Sebolt-Leopold, Judith
    ONCOTARGET, 2017, 8 (39) : 65090 - 65099
  • [23] Endothelial ADAM17 Expression in the Progression of Kidney Injury in an Obese Mouse Model of Pre-Diabetes
    Palau, Vanesa
    Jarrin, Josue
    Villanueva, Sofia
    Benito, David
    Marquez, Eva
    Rodriguez, Eva
    Soler, Maria Jose
    Oliveras, Anna
    Gimeno, Javier
    Sans, Laia
    Crespo, Marta
    Pascual, Julio
    Barrios, Clara
    Riera, Marta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
  • [24] ADAM17 promotes glioma cell progression through EGFR-PI3K-AKT activation
    Zheng, Xuguang
    Jiang, Feng
    Katakowski, Mark
    Lu, Yong
    Chopp, Michael
    CANCER RESEARCH, 2011, 71
  • [25] MICRORNA-494 TARGETS CXCR4 TO SUPPRESS PROSTATE CANCER PROGRESSION AND METASTASIS
    Pengfei, S.
    Jia, W.
    Hao, Z.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 187 - 187
  • [26] miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17
    Yang, Xue-wei
    Zhang, Long-juan
    Huang, Xiao-hui
    Chen, Lian-zhou
    Su, Qiao
    Zeng, Wen-tao
    Li, Wen
    Wang, Qian
    HEPATOLOGY RESEARCH, 2014, 44 (05) : 551 - 559
  • [27] ADAM17 Deletion in Thymic Epithelial Cells Alters Aire Expression without Affecting T Cell Developmental Progression
    Gravano, David M.
    McLelland, Bryce T.
    Horiuchi, Keisuke
    Manilay, Jennifer O.
    PLOS ONE, 2010, 5 (10):
  • [28] GPR50 Promotes Hepatocellular Carcinoma Progression via the Notch Signaling Pathway through Direct Interaction with ADAM17
    Saha, Subbroto Kumar
    Choi, Hye Yeon
    Yang, Gwang-Mo
    Biswas, Polash Kumar
    Kim, Kyeongseok
    Kang, Geun-Ho
    Gil, Minchan
    Cho, Ssang-Goo
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 17 : 332 - 349
  • [29] Periostin derived from cancer-associated fibroblasts promotes esophageal squamous cell carcinoma progression via ADAM17 activation
    Ishibashi, Yusuke
    Mochizuki, Satsuki
    Horiuchi, Keisuke
    Tsujimoto, Hironori
    Kouzu, Keita
    Kishi, Yoji
    Okada, Yasunori
    Ueno, Hideki
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (05):
  • [30] Modulation of cytokine trans-signaling by microRNA-21 (miR-21)-mediated regulation of TACE/ADAM17 in the diabetic retina
    Bartoli, Manuela
    Lamoke, Folami
    Shaw, Sean
    Gutsaeva, Diana
    Baban, Babak
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)